Medical Devices APAC

APAC Neurorehabilitation Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Neurorehabilitation Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $385.9 Mn Placeholder estimate
Estimate 2025 $434.9 Mn 22.1% of the global market
Projected 2034 $1.28 Bn 193.3% Adds $840.7 Mn over 9 forecast years
CAGR 2025–2034 12.7% Faster than 71% of 186 Medical Devices markets here
Key players 5 Companies profiled
  • APAC is 22.06% of the global market.
  • Among regions, the largest is North America at $861.9 Mn.
  • Fastest growing: APAC (this report) at 12.7% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$840.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Neurorehabilitation Devices Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $385.9 Mn — —
2025 (base) $434.9 Mn +$49.0 Mn —
2026 (forecast) $490.1 Mn +$55.2 Mn +12.7%
2027 (forecast) $552.4 Mn +$62.2 Mn +27%
2028 (forecast) $622.5 Mn +$70.2 Mn +43.1%
2029 (forecast) $701.6 Mn +$79.1 Mn +61.3%
2030 (forecast) $790.7 Mn +$89.1 Mn +81.8%
2031 (forecast) $891.1 Mn +$100.4 Mn +104.9%
2032 (forecast) $1.00 Bn +$113.2 Mn +130.9%
2033 (forecast) $1.13 Bn +$127.5 Mn +160.3%
2034 (forecast) $1.28 Bn +$143.7 Mn +193.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Neurorehabilitation Devices Market Analysis at a glance
Market size, 2025$434.9 Mn placeholder estimate
Forecast, 2034$1.28 Bn placeholder estimate
Growth (CAGR), 2025–203412.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, condition and end user (see all)
Key playersHocoma (DIH), Ekso Bionics, ReWalk Robotics, Bioness, MindMaze (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Neurorehabilitation Devices Market Analysis Executive Summary

Neurorehabilitation devices help people recover movement after stroke or brain injury, using robots, stimulation and virtual reality.

Key segments of the neurorehabilitation Devices market include product (Rehabilitation Robots, Brain Stimulation Devices and Wearable Sensors) and condition (Stroke, Spinal Cord Injury and Traumatic Brain Injury).

Bar chart: Asia Pacific Neurorehabilitation Devices market size, 2024–2034, placeholder estimates. $385.9 Mn in 2024, $434.9 Mn in 2025 and $1.28 Bn in 2034, 12.7% CAGR.
Asia Pacific Neurorehabilitation Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Neurorehabilitation Devices Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurorehabilitation Devices market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the neurorehabilitation Devices market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the neurorehabilitation Devices market.

Competitive Landscape for Neurorehabilitation Devices Market in APAC

The neurorehabilitation Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Neurorehabilitation Devices Market in APAC

Neurorehabilitation Devices in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9], Thai FDA (Thailand)⁠[10], Ministry of Health (Indonesia)⁠[11], DRAP (Pakistan)⁠[12], MFDS (South Korea)⁠[13] and Ministry of Health (Vietnam)⁠[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[15], basic medical insurance (China)⁠[16], the Hospital Authority (Hong Kong)⁠[17], Ayushman Bharat PM-JAY (India)⁠[18], public health insurance (Japan)⁠[19], subsidised public care (Malaysia)⁠[20], Pharmac (New Zealand)⁠[21], PhilHealth (Philippines)⁠[22], MediShield Life (Singapore)⁠[23], the Universal Coverage Scheme (Thailand)⁠[24], JKN (BPJS Kesehatan) (Indonesia)⁠[25], out of pocket and Sehat Sahulat (Pakistan)⁠[26], National Health Insurance (South Korea)⁠[27] and social health insurance (Vietnam)⁠[28].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Ministry of Health of Indonesia. Checked 19 Nov 2026.

[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.

[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.

[14] Ministry of Health of Vietnam. Checked 19 Nov 2026.

[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[16] National Healthcare Security Administration. Checked 14 Nov 2026.

[17] Hospital Authority. Checked 14 Nov 2026.

[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[20] Ministry of Health Malaysia. Checked 14 Nov 2026.

[21] Pharmac. Checked 14 Nov 2026.

[22] PhilHealth. Checked 14 Nov 2026.

[23] CPF Board, MediShield Life. Checked 14 Nov 2026.

[24] National Health Security Office. Checked 14 Nov 2026.

[25] BPJS Kesehatan. Checked 19 Nov 2026.

[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[28] Vietnam Social Security. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurorehabilitation Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Neurorehabilitation Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Neurorehabilitation Devices in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Neurorehabilitation Devices market in Asia Pacific?
Placeholder estimate: about $434.9 Mn in 2025, rising to about $1.28 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Neurorehabilitation Devices market in Asia Pacific growing?
Placeholder estimate: about 12.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Neurorehabilitation Devices market report cover?
The report splits the market by product (Rehabilitation Robots, Brain Stimulation Devices, Wearable Sensors, VR Systems), condition (Stroke, Spinal Cord Injury, Traumatic Brain Injury) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Neurorehabilitation Devices market?
Key players include Hocoma (DIH), Ekso Bionics, ReWalk Robotics, Bioness and MindMaze.
What is driving the Neurorehabilitation Devices market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurorehabilitation Devices market.
How much research is published on Neurorehabilitation Devices?
PubMed lists 427 papers on Neurorehabilitation Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on rehabilitation and stroke

See the topic